janvier 2023

Olink

Olink

Passive Bookrunner (Follow-On Offering)

Canaccord Genuity Acts as Passive Bookrunner to Olink Holding on its Follow-On Offering

More Like This

US$92m

décembre 2024

Candel Therapeutics

Joint Bookrunner (CMPO)
décembre 2024

Neuronetics

Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
novembre 2024

UCB

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma

Afficher les transactions Healthcare